UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Hirsutine ameliorates hepatic and cardiac insulin resistance in high-fat diet-induced diabetic mice and in vitro models Journal article
Hu, Wei, Li, Meng, Sun, Wuyi, Li, Qixiu, Xi, Haiyan, Qiu, Yuanye, Wang, Ran, Ding, Qian, Wang, Zhou, Yu, Yue, Lei, Heping, Mao, Yicheng, Zhu, Yi Zhun. Hirsutine ameliorates hepatic and cardiac insulin resistance in high-fat diet-induced diabetic mice and in vitro models[J]. Pharmacological Research, 2022, 177.
Authors:  Hu, Wei;  Li, Meng;  Sun, Wuyi;  Li, Qixiu;  Xi, Haiyan; et al.
Favorite | TC[WOS]:23 TC[Scopus]:27  IF:9.1/9.0 | Submit date:2022/09/21
Glucose Metabolism  Hfd  Hirsutine  Insulin Resistance  Pi3k/akt Signaling  T2dm  
Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds Review article
2020
Authors:  Nie, Xin;  Chen, Zhejie;  Pang, Lan;  Wang, Lin;  Jiang, Huajuan; et al.
Favorite | TC[WOS]:42 TC[Scopus]:52 | Submit date:2023/04/19
Antidiabetic Effects  Drug Delivery Systems  Nanoparticles (Nps)  Phytocompounds  Type 2 Diabetes Mellitus (T2dm)  
Differential HbA1c response in the placebo arm of DPP-4 inhibitor clinical trials conducted in China compared to other countries: A systematic review and meta-analysis Journal article
He L., Liu S., Shan C., Tu Y., Li Z., Zhang X.D.. Differential HbA1c response in the placebo arm of DPP-4 inhibitor clinical trials conducted in China compared to other countries: A systematic review and meta-analysis[J]. BMC Pharmacology and Toxicology, 2016, 17(1).
Authors:  He L.;  Liu S.;  Shan C.;  Tu Y.;  Li Z.; et al.
Favorite | TC[WOS]:4 TC[Scopus]:5 | Submit date:2018/12/21
Diabetes Mellitus  Differential Hba1c Response  Dipeptidyl Peptidase-4 Inhibitor  Meta-analysis  T2dm